BioCentury | Feb 24, 2014
Tools & Techniques

Bigger is better

...a library also in the millions. In 2007, GlaxoSmithKline plc acquired Praecis Pharmaceuticals Inc. for $54.8 million. Praecis...
...molecule library that contained about 10 billion members. Wagner, who was EVP of research at Praecis...
BioCentury | Sep 17, 2012
Product Development

Excited about cycling

...see BioCentury, June 11). GlaxoSmithKline plc obtained a similar DNA-encoded library technology when it acquired Praecis Pharmaceuticals Inc....
...Barry Morgan, VP of molecular discovery research at GSK and former VP of chemistry at Praecis...
BioCentury | Nov 21, 2011
Regulation

Provenge politics

...actually was requested by Praecis Pharmaceuticals Inc. to ensure that coverage was consistent with an FDA-mandated REMS. Praecis...
BioCentury | Oct 25, 2010
Clinical News

Abarelix regulatory update

...marketed as Plenaxis in Germany to treat prostate cancer. In 2007, Speciality acquired abarelix from Praecis Pharmaceuticals Inc....
BioCentury | Jul 5, 2010
Regulation

Ring-fence for Provenge

...request of the sponsor, Praecis Pharmaceuticals Inc. in an effort to overcome concerns about life-threatening adverse events. Praecis...
BioCentury | Nov 12, 2007
Company News

SRU Biosystems management update

...screening Hired: Richard Wagner as president, CEO and a director, formerly EVP of research at Praecis Pharmaceuticals Inc....
BioCentury | Oct 1, 2007
Finance

Repeat performance?

...$120M in stock 12/18/06 Icos (A) Eli Lilly $27.12 $34.00 25% $2.3B in cash 12/21/06 Praecis...
BioCentury | Feb 26, 2007
Company News

Praecis, GlaxoSmithKline deal

...two more tranches for a total of $8.6 million by the end of this quarter. Praecis Pharmaceuticals Inc....
BioCentury | Feb 12, 2007
Finance

Ebb & Flow

...undisclosed amount of cash and bought worldwide rights to prostate cancer drug Plenaxis abarelix from Praecis...
BioCentury | Feb 12, 2007
Company News

Speciality European Pharma, Praecis, Proreo Pharma International AG deal

...LSE:GSK, GSK, London, U.K.) (see BioCentury, Jan. 1). Speciality European Pharma Ltd. , London, U.K. Praecis Pharmaceuticals Inc....
Items per page:
1 - 10 of 206
BioCentury | Feb 24, 2014
Tools & Techniques

Bigger is better

...a library also in the millions. In 2007, GlaxoSmithKline plc acquired Praecis Pharmaceuticals Inc. for $54.8 million. Praecis...
...molecule library that contained about 10 billion members. Wagner, who was EVP of research at Praecis...
BioCentury | Sep 17, 2012
Product Development

Excited about cycling

...see BioCentury, June 11). GlaxoSmithKline plc obtained a similar DNA-encoded library technology when it acquired Praecis Pharmaceuticals Inc....
...Barry Morgan, VP of molecular discovery research at GSK and former VP of chemistry at Praecis...
BioCentury | Nov 21, 2011
Regulation

Provenge politics

...actually was requested by Praecis Pharmaceuticals Inc. to ensure that coverage was consistent with an FDA-mandated REMS. Praecis...
BioCentury | Oct 25, 2010
Clinical News

Abarelix regulatory update

...marketed as Plenaxis in Germany to treat prostate cancer. In 2007, Speciality acquired abarelix from Praecis Pharmaceuticals Inc....
BioCentury | Jul 5, 2010
Regulation

Ring-fence for Provenge

...request of the sponsor, Praecis Pharmaceuticals Inc. in an effort to overcome concerns about life-threatening adverse events. Praecis...
BioCentury | Nov 12, 2007
Company News

SRU Biosystems management update

...screening Hired: Richard Wagner as president, CEO and a director, formerly EVP of research at Praecis Pharmaceuticals Inc....
BioCentury | Oct 1, 2007
Finance

Repeat performance?

...$120M in stock 12/18/06 Icos (A) Eli Lilly $27.12 $34.00 25% $2.3B in cash 12/21/06 Praecis...
BioCentury | Feb 26, 2007
Company News

Praecis, GlaxoSmithKline deal

...two more tranches for a total of $8.6 million by the end of this quarter. Praecis Pharmaceuticals Inc....
BioCentury | Feb 12, 2007
Finance

Ebb & Flow

...undisclosed amount of cash and bought worldwide rights to prostate cancer drug Plenaxis abarelix from Praecis...
BioCentury | Feb 12, 2007
Company News

Speciality European Pharma, Praecis, Proreo Pharma International AG deal

...LSE:GSK, GSK, London, U.K.) (see BioCentury, Jan. 1). Speciality European Pharma Ltd. , London, U.K. Praecis Pharmaceuticals Inc....
Items per page:
1 - 10 of 206